Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,147
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
for
Extensive-stage Small-cell Lung Cancer
Location: Fountain Hill PA, New York NY, White Plains NY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712355
Phase3, Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
for
Endometrial Cancer, Malignant Solid Tumour
Location: Bethlehem PA, Willow Grove PA, Hershey PA, Paramus NJ,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07044336
Phase3, Recruiting
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
for
Staphylococcus Aureus
Location: Bethlehem PA, Jersey City NJ, Ridgewood NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 55
Code: NCT06749457
Phase1, Phase2, Recruiting
Observational Study Protocol: LIVER-R
for
Hepatobiliary Cancers
Location: Bethlehem PA, Philadelphia PA, Lancaster PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06252753
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Bethlehem PA, Bridgewater NJ, Cherry Hill NJ,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Project PEAK: Early Intervention for ADHD
for
Attention Deficit Hyperactivity Disorder,
Location: Bethlehem PA
Sponsor: Lehigh University
Sex: All
Age: 3 - 5
Code: NCT04627415
Recruiting
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Sellersville PA, Philadelphia PA, Morristown NJ,